U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ORMUTIVIMAB
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(RABIES LYSSAVIRUS GLYCOPROTEIN EPITOPE G-I) (HUMAN MONOCLONAL NM57 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL NM57 .LAMBDA.-CHAIN, DIMER
Preferred Name English
Ormutivimab [WHO-DD]
Common Name English
ormutivimab [INN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C184868
Created by admin on Wed Apr 02 12:32:34 GMT 2025 , Edited by admin on Wed Apr 02 12:32:34 GMT 2025
PRIMARY
INN
11825
Created by admin on Wed Apr 02 12:32:34 GMT 2025 , Edited by admin on Wed Apr 02 12:32:34 GMT 2025
PRIMARY
FDA UNII
N7NY3SG25X
Created by admin on Wed Apr 02 12:32:34 GMT 2025 , Edited by admin on Wed Apr 02 12:32:34 GMT 2025
PRIMARY
SMS_ID
300000039123
Created by admin on Wed Apr 02 12:32:34 GMT 2025 , Edited by admin on Wed Apr 02 12:32:34 GMT 2025
PRIMARY
CAS
2449086-91-1
Created by admin on Wed Apr 02 12:32:34 GMT 2025 , Edited by admin on Wed Apr 02 12:32:34 GMT 2025
PRIMARY
ACTIVE MOIETY
ORMUTIVIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966